Education
About Us
Working with TipRanks
Follow Us
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
Esomeprazole, Nx-5948 Capsule, Nx-5948 Tablet
Healthy Volunteer
Phase I
Recruiting
Relative Bioavailability of NX-5948 Tablets Vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets
Dec 01, 2024
―
Nx-5948
Healthy Volunteer
Phase I
Completed
Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948
Nov 01, 2024
―
Ip
Healthy Volunteers
Phase I
Completed
A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects
Sep 05, 2024
―
Nx-5948
Follicular Lymphoma (Fl), Primary Central Nervous System Lymphoma (Pcnsl), Small Lymphocytic Lymphoma (Sll), Chronic Lymphocytic Leukemia (Cll), Marginal Zone Lymphoma (Mzl), Mantle Cell Lymphoma (Mcl), Waldenstrom Macroglobulinemia (Wm), Diffuse Large B Cell Lymphoma (Dlbcl), Secondary Central Nervous System Lymphoma (Scnsl)
Phase I
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nov 12, 2021
―
Paclitaxel, Nx-1607
Cervical Cancer, Non-Small Cell Lung Cancer (Nsclc), Gastric Cancer, Head And Neck Squamous Cell Carcinoma, Malignant Pleural Mesothelioma (Mpm), Metastatic Castration-Resistant Prostate Cancer (Mcrpc), Triple Negative Breast Cancer (Tnbc), Microsatellite Stable Colorectal Carcinoma, Diffuse Large B Cell Lymphoma (Dlbcl), Gastroesophageal Junction (Gej) Cancer, Ovarian Cancer, Epithelial, Metastatic Urothelial Carcinoma, Metastatic Or Unresectable Melanoma, Richter Transformation
Phase I
Recruiting
A Study of NX-1607 in Adults With Advanced Malignancies
Sep 22, 2021
―
Nx-2127
Follicular Lymphoma (Fl), Primary Central Nervous System Lymphoma (Pcnsl), Diffuse Large B-Cell Lymphoma (Dlbcl), Small Lymphocytic Lymphoma (Sll), Chronic Lymphocytic Leukemia (Cll), Marginal Zone Lymphoma (Mzl), Mantle Cell Lymphoma (Mcl), Waldenstrom Macroglobulinemia (Wm)
Phase I
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Mar 29, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Nurix Therapeutics (NRIX) have in its pipeline
NRIX is currently developing the following drugs: Esomeprazole, Nx-5948 Capsule, Nx-5948 Tablet, Nx-5948, Ip. These drug candidates are in various stages of clinical development as the company works toward FDA approval.